To mimic the structural features of alpha‐synuclein amyloid fibrils and design vaccine candidates targeting synucleinopathies, a scaffold protein was selected to introduce exposed amino acids from the surface of alpha‐synuclein fibril structures in a structurally controlled manner. Here, SNCA is linked to synucleinopathy.